Overview

Study to Evaluate the Effect on Lung Function and ECG When a Combination of Tiotropium Plus Olodaterol is Administered to Patients With COPD Either From a Single Inhaler or Each Compound is Administered After Each Other From Two Different Inhalers

Status:
Completed

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the efficacy and safety of orally inhaled tiotropium and olodaterol as both a fixed dose combination and a free combination with respect to lung function and ECG parameters

Phase:

Phase 2

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Olodaterol
Tiotropium Bromide